InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 16.10
-0.10 (-0.62%)
Jan 22, 2026, 2:02 PM CST
InnoPharmax Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -106.95 | -99.29 | -70.83 | -103.18 | -92.97 | -43.9 | Upgrade |
Depreciation & Amortization | 6.39 | 6.55 | 7.2 | 8.35 | 9.48 | 14.22 | Upgrade |
Other Amortization | 0.05 | 0.06 | 0.04 | 0.02 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | 0.03 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 1.4 | - | 3.16 | 3.66 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | 2 | - | Upgrade |
Loss (Gain) on Equity Investments | 9.74 | 8.12 | 9.3 | 5.82 | 13.32 | 10.27 | Upgrade |
Stock-Based Compensation | 1.02 | 1.24 | 1.76 | 2.37 | 0.66 | 0.32 | Upgrade |
Provision & Write-off of Bad Debts | 1.34 | 6.09 | - | -0.5 | -0.83 | 1.9 | Upgrade |
Other Operating Activities | 3.19 | 3.24 | 0.22 | 0.22 | 0.29 | 0.06 | Upgrade |
Change in Accounts Receivable | -0.3 | 2.42 | -6.96 | 0.5 | 6.47 | -13.54 | Upgrade |
Change in Inventory | -2.5 | 3.9 | 7.78 | -14.44 | 29.18 | -22.14 | Upgrade |
Change in Accounts Payable | -6.4 | -4.16 | 5.72 | - | -26.87 | 21.53 | Upgrade |
Change in Unearned Revenue | 4.6 | 2.26 | - | - | - | -3.27 | Upgrade |
Change in Other Net Operating Assets | -9.59 | -6.67 | -4.21 | 0.75 | 6.09 | -16.48 | Upgrade |
Operating Cash Flow | -99.42 | -76.22 | -48.57 | -100.08 | -50.03 | -47.37 | Upgrade |
Capital Expenditures | -0.53 | -0.53 | -0.4 | - | -1.45 | - | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0.03 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | -0.06 | - | -0.13 | - | -1.86 | Upgrade |
Investment in Securities | 0.46 | -14.56 | -48.91 | 32.71 | -36.22 | -18.18 | Upgrade |
Other Investing Activities | -2.03 | -0.44 | -0.7 | -1.3 | 1.06 | - | Upgrade |
Investing Cash Flow | -2.1 | -15.59 | -50.01 | 31.32 | -36.6 | -20.04 | Upgrade |
Short-Term Debt Issued | - | - | - | 23.27 | - | - | Upgrade |
Total Debt Issued | 6.5 | - | - | 23.27 | - | - | Upgrade |
Short-Term Debt Repaid | - | -1.5 | -11.77 | - | -20 | - | Upgrade |
Long-Term Debt Repaid | - | -4.48 | -4.42 | -4.5 | -4.42 | -4.34 | Upgrade |
Total Debt Repaid | -4.52 | -5.98 | -16.19 | -4.5 | -24.42 | -4.34 | Upgrade |
Net Debt Issued (Repaid) | 1.98 | -5.98 | -16.19 | 18.77 | -24.42 | -4.34 | Upgrade |
Issuance of Common Stock | 225 | 225.16 | 113.6 | - | 20.15 | - | Upgrade |
Other Financing Activities | - | - | - | - | - | 127.09 | Upgrade |
Financing Cash Flow | 226.98 | 219.18 | 97.41 | 18.77 | -4.26 | 122.75 | Upgrade |
Net Cash Flow | 125.46 | 127.37 | -1.17 | -49.98 | -90.89 | 55.34 | Upgrade |
Free Cash Flow | -99.95 | -76.75 | -48.97 | -100.08 | -51.48 | -47.37 | Upgrade |
Free Cash Flow Margin | -179.20% | -237.64% | -106.29% | -343.51% | -107.11% | -34.61% | Upgrade |
Free Cash Flow Per Share | -0.96 | -0.79 | -0.53 | -1.15 | -0.60 | -0.62 | Upgrade |
Cash Interest Paid | 0.38 | 0.32 | 0.19 | 0.06 | 0.04 | 0.61 | Upgrade |
Cash Income Tax Paid | 0.06 | 0.18 | -0.1 | - | - | - | Upgrade |
Levered Free Cash Flow | -67.62 | -45.78 | -34.59 | -64.47 | -159.12 | 91.88 | Upgrade |
Unlevered Free Cash Flow | -67.38 | -45.59 | -34.36 | -64.31 | -158.87 | 92.27 | Upgrade |
Change in Working Capital | -14.19 | -2.23 | 2.33 | -13.2 | 14.87 | -33.9 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.